Literature DB >> 5018311

Dextrose and sorbitol as diluents for continuous intravenous heparin infusion.

J M Chessells, T A Braithwaite, D A Chamberlain.   

Abstract

A comparison of 5% dextrose and 5% sorbitol as diluents for heparin given by continuous intravenous infusion indicated that neither impaired the potency of the heparin. Previous suggestions that heparin becomes unstable in dextrose solution have not been confirmed.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5018311      PMCID： PMC1787877          DOI： 10.1136/bmj.2.5805.81

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  8 in total

1.  STABILITY OF HEPARIN SOLUTIONS.

Authors:  J PRITCHARD
Journal:  J Pharm Pharmacol       Date:  1964-07       Impact factor: 3.765

2.  Portable heparin injector.

Authors:  J O'Riordan; W MacGowan
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

3.  Heparin requirements in patients with acute myocardial infarction.

Authors:  J F Pombo; R O Russell; G L Foster
Journal:  Arch Intern Med       Date:  1970-12

4.  The activated partial thromboplastin time in the control of heparin treatment.

Authors:  J Hirsh; E F O'Sullivan; A S Gallus; M Martin
Journal:  Australas Ann Med       Date:  1970-11

5.  Heparin in acid solutions.

Authors:  S L Stock; N Warner
Journal:  Br Med J       Date:  1971-07-31

6.  Modern drug treatment and potential hazards to health.

Authors:  R H Girdwood
Journal:  Scott Med J       Date:  1971-08       Impact factor: 0.729

7.  Heparin administration by constant infusion pump.

Authors:  A J Handley
Journal:  Br Med J       Date:  1967-05-20

8.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17
  8 in total
  5 in total

1.  Anticoagulant activity of heparin in intravenous fluids.

Authors:  T Okuno; C A Nelson
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

2.  Letter: Streptokinase and heparin in treatment of pulmonary embolism.

Authors:  D A Tibbutt; A A Sharp; J M Holt; G Miller; G Sutton
Journal:  Br Med J       Date:  1974-06-15

3.  Intravenous infusions of heparin and penicillins.

Authors:  J Jacobs; D Kletter; E Superstine; K R Hill; B Lynn; R A Webb
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

4.  Heparin stability: effects of diluent, heparin activity, container, and pH.

Authors:  K T Goodall; C C Chooi; A S Gallus
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

Review 5.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.